CN Stock MarketDetailed Quotes

301015 Qingdao Baheal Medical INC.

Watchlist
  • 32.35
  • +0.78+2.47%
Market Closed Apr 30 15:00 CST
17.00BMarket Cap24.29P/E (TTM)

About Qingdao Baheal Medical INC. Company

The company was founded in 2005 and is a leading A-share health brand commercialization platform. Its core business focuses on brand operation and construction of high-quality global medical and health products, and effectively optimizes medical scenarios through scientific and technological innovation. The company's main business is to provide overall commercial solutions for pharmaceutical product manufacturers, covering the three sectors of brand operation, wholesale distribution and retail. Main products or businesses: Operates brands such as Diqao series, Hale series, Takeda series, Roche series, Keonis, Esnona, Neutschuma, Atricure, Fuzhenghua, Zisheng, etc.; distributes pharmaceuticals, Chinese medicine tablets, medical devices, diagnostic reagents, medical consumables, etc.; sells pharmaceuticals, medical devices, health food, cosmetics, etc. Corporate honors: 2021 Shandong Top 50 Service Enterprises, First Batch of Chinese OTC Brand Clusters, 2021 Pharmaceutical Industry “13th Five-Year” Enterprise Management Award - Outstanding Growth Enterprise, etc.

Company Profile

Short Name-A百洋医药
Symbol-A301015
Company NameQingdao Baheal Medical INC.
Listing DateJun 30, 2021
Issue Price7.64
Shares Offered52.60M share(s)
FoundedMar 8, 2005
Legal Representativegang fu
CEOgang fu
Secretaryguoqiang wang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativenina liu
Legal CounselBeijing Tianyuan Law Firm
Employees1686
Phone0532-66756688
Office AddressNo. 88 Kaifeng Road, Shibei District, Qingdao, Shandong
Zip Code266042
Registered AddressNo. 88 Kaifeng Road, Shibei District, Qingdao, Shandong
Fax0532-67773768
Emailbyyy@baheal.com
BusinessLicense items: drug retail; pharmaceutical wholesale; Class III medical device management; Class III medical device leasing; urban distribution and transportation services (excluding dangerous goods); Class II value-added telecommunications services; Internet information services; road cargo transportation (excluding dangerous goods). (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses). General items: import and export of goods; food sales (sale of pre-packaged food only); Internet sales of food (sale of pre-packaged food only); sale of infant formula and other infant formula; sales of health food (pre-packaged); sale of formula food for special medical purposes; sale of class I medical devices; sales of class II medical devices; retail sales of sporting goods and equipment; retail of cosmetics; retail of household goods; wholesale of kitchen utensils and household goods; sale of disinfectants (excluding hazardous chemicals); sale of household appliances; repair of special equipment; leasing of Class II medical devices; low-temperature storage (not included) Dangerous chemicals, etc.); general cargo storage services (excluding hazardous chemicals, etc.); technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion; health consulting services (excluding diagnosis and treatment services); marketing planning; information consulting services (excluding licensed information consulting services); non-residential real estate leasing; technology import and export. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • gang fu
  • Chairman,directors,general manager
  • 3.59M
  • qing song
  • directors,Audit Committee Member
  • --
  • yuan zhang
  • directors,Deputy General Manager
  • 2.61M
  • xiaowei zhu
  • directors,Deputy General Manager
  • 2.46M
  • guoqiang wang
  • directors,Board Secretary,Deputy General Manager,Chief Financial Officer
  • 2.54M
  • haishen chen
  • directors
  • --
  • mingzhong fu
  • Independent directors
  • 150.00K
  • xianjing hao
  • Independent directors
  • 150.00K
  • yindi lu
  • Independent directors
  • 150.00K
  • nina liu
  • Securities affairs representative
  • --
  • jun mou
  • Chairman of the Supervisory Board,auditors
  • --
  • xuebiao li
  • auditors
  • 1.30M
  • tingwei wang
  • Deputy General Manager
  • 2.61M
  • biquan wang
  • Deputy General Manager
  • 2.50M
  • nan du
  • Employee supervisors
  • 1.18M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg